Navigation Links
St. Jude Study Shows Effectiveness of Peramivir in Prevention of,Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection

rom US FDA and the availability of an intravenous neuraminidase inhibitor may be important in treating patients hospitalized with severe and potentially life-threatening influenza. The availability of an intramuscular formulation of peramivir could ensure appropriate dosing which may be a concern with currently available oral or inhaled anti-influenza agents.

About Influenza

The influenza virus causes an acute viral disease of the respiratory tract. Unlike the common cold and some other respiratory infections, seasonal flu can cause severe illness, resulting in life-threatening complications. According to the Centers for Disease Control and Prevention, every year in the United States more than 200,000 people are hospitalized from flu complications, and about 36,000 people die from flu. Most at risk are young children, the elderly, and people with seriously compromised immune systems.

Avian influenza A viruses of H5N1 subtype are circulating among birds worldwide, the virus is considered extremely contagious in fowl. It is believed that all species of birds are susceptible to avian influenza, but domestic poultry, including chickens and turkeys, are among the more susceptible to the highly pathogenic strain. According to the World Health Organization, at least 261 people have contracted H5N1 avian influenza, of which at least 157 have died. Almost all of these infections are believed to have resulted from contact with infected poultry.

About BioCryst

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine(TM) in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a worldwide
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:8/29/2014)... -- Research and Markets has announced the ... of Pharmaceutical Equipment Market in China, 2014-2018" report ... Trend Forecast of Pharmaceutical Equipment Market in ... pharmaceutical equipment industry in the aspects of ... business performance of domestic major enterprises, as well as ...
(Date:8/29/2014)... , Aug. 29, 2014  Unilife Corporation ("Unilife" ... announced today that it intends to release its financial ... ended June 30, 2014 after market trading ends on ... scheduled a conference call for 4:30 p.m. U.S. EDT ... at 6:30 a.m. AEST), to review the Company,s financial results, ...
(Date:8/29/2014)... 2014  Pacific Medical Data Solutions is excited to ... . The main website, along with the site,s blog, ... services and content relevant to the medical billing industry. ... viewers can now better understand how PMDS products help ... create a more visible platform about medical billing best ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2PMDS Announces New Website 2
... 2011 Mylan Inc. (Nasdaq: MYL ) ... Matrix Laboratories Limited) has received approval for three antiretroviral ... Health Organization,s (WHO) Prequalification of Medicines Programme. The products ... Tablet, 100 mg (heat-stable), and Tenofovir Disoproxil Fumarate and ...
... Medical imaging has revolutionized healthcare and is essential ... Modern equipment and protocols ensure that patients, physicians, and ... radiation, while still providing accurate results and diagnostic information. ... medical procedure must be balanced with the benefits of ...
Cached Medicine Technology:Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment 2Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment 3Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment 4AAPM Cautions that Patients Should Not Forgo Essential Medical Imaging 2
(Date:8/29/2014)... 2014 Carson Hearing Care has launched ... health care tips to local residents on a consistent ... offer weekly articles from the audiologists at Carson Hearing ... latest advances in hearing restoration research, new tinnitus treatment ... plan to write a new post on the blog ...
(Date:8/29/2014)... new report released yesterday by the Mental Health ... mental health training and education that police personnel ... prominent issue for Canada,s police community, and today,s ... law enforcement and people with mental illnesses," says ... with an interest in the area of police ...
(Date:8/29/2014)... team of scientists from the University of Colorado School ... process to expand production of stem cells used to ... extend beyond cancer, including treatments for inborn immunodeficiency and ... published Aug. 29 in PLOS ONE , ... Medicine and Stem Cell Biology and Taiga Biotechnologies, Inc. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 LiveOps, Inc., ... service solutions, today announced that LiveOps has been selected ... Association's (MDA) Show of Strength Telethon for the third ... raises money and awareness to support MDA’s mission to ... aggressive and sometimes fatal muscle disease. This year’s program ...
(Date:8/29/2014)... Steven Reinberg ... News) -- The vast majority of American babies are ... serious illnesses, federal health officials said Thursday. More ... that prevent measles, mumps, and rubella (MMR); polio; hepatitis ... for Disease Control and Prevention. "Nationally, vaccination among ...
Breaking Medicine News(10 mins):Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 3Health News:Report advocates improved police training 2Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3
... Liposuction and Body/Facial Reshaping visualizations TORONTO, May ... intelligent, life-like facial and body simulations performed ... of its latest plastic surgery visualization tool, ... LiftMagic.com, a popular online anti-aging visualization tool ...
... Development Authority, highlights New Jersey,s talented workforce and ... prosperityPARSIPPANY, N.J., May 13 Daiichi Sankyo, Inc. ... completed a major renovation and build-out of the ... facility to accommodate its growing workforce, creating sole ...
... announces that it has enrolled its 1,000th patient into ... R esponsiveness with A V erifyNow(R) Assay ... S afety). The trial is specifically designed to ... for patients who are poor responders to clopidogrel (Plavix(R)). ...
... Who: JEFFERSONS RESTAURANT VIP PREMIERE GALA, ... When: 5pm on Monday, May 18, 2009, ... Nashville,s historic Jefferson Street is known for its legendary live concerts with ... each contributing to the ambience of the rich R/B history of this ...
... High serum ferritin, being a hallmark of hereditary ... C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty ... has investigated the link between ferritin and steatosis ... southern European populations, high ferritin levels, after exclusion ...
... RWD(R) Healthcare Practice to Streamline Patient Flow and Improve ... some hospitals are struggling financially, St. Luke,s Episcopal Hospital ... efficient patient care with quality at its core. In ... is streamlining its transfer process for patients who need ...
Cached Medicine News:Health News:ModiFace Launches ReShapr.com, the World's First Free Online Plastic Surgery Visualization Tool 2Health News:Daiichi Sankyo, Inc. Celebrates the Growth of Its U.S. Headquarters 2Health News:Daiichi Sankyo, Inc. Celebrates the Growth of Its U.S. Headquarters 3Health News:Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial 2Health News:Belmont University Graduate Launches Healthy Soul Food Restaurant on Nashville's Historic Jefferson Street 2Health News:St. Luke's Episcopal Hospital Announces Latest Phase of Efficiency, Excellence and Engagement Campaign 2Health News:St. Luke's Episcopal Hospital Announces Latest Phase of Efficiency, Excellence and Engagement Campaign 3Health News:St. Luke's Episcopal Hospital Announces Latest Phase of Efficiency, Excellence and Engagement Campaign 4
... standard trial frames. They are made of optical quality ... box. There are two sets available providing a full ... is that a patient can wear the prism with ... the patient to adapt to the use of the ...
... C Dermatome - reaching a new evolutionary plateau. ... to operate in the pulse mode, or to ... entire instrument and hose assembly is autoclavable and ... 2-, 3-, or 4-inch widths. Simply select the ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator (Fenzl), blunt tip angled 45, 12.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge ind...
Medicine Products: